May. 8 at 6:54 PM
$BCAB Part III: If BCAB suddenly has
$7-10M in cash, with a large portfolio of assets still on its books, then the stock should cure the min market cap on its own by jumping to
$22 or higher, at which point they will likely employ the SEPA to raise another
$2-3M. I don't foresee BCAB ever rehiring and being a functional BioTech company again. Far from it. It is a holding company right now for some (potentially) very valuable assets. If they sell Oz-V for
$10-15M upfront and some backend, the stock will be
$30-40 the next day, cured of all NASDAQ issues, and still have EpCam and their CAB platform to sell. That's 7-9x from here, and that's jsut when the positive loop gets going. But, this is JUST A HYPOTHETICAL. For all I know, Oz-V could be sold for
$14 and NASDAQ delists on Monday.
